- News
- About us
- Annual Research Programmes
- Annual Research Programme 2026
- MELs
- Follow-up human genetics
- Digital Health Technologies (Ongoing Consultations)
- Integrated Digital Wound Management Systems
- Hospital-based Health Technology Assessment for AI-based Digital Health Technologies
- ASSESS-DHT
- HTAR
- Joint Clinical Assessments Medical Devices
- Oral Nutritional Supplements
- Promoting oral health in children
- Effectiveness of health warning labels on alcoholic beverages
- Measures to reduce weight stigma
- Assessment of Interventions Addressing Social Media Use among Children and Adolescents
- Health navigators
- FALCO
- Connecting Minds
- HTAs for the Austrian Appraisal Board
- HTAR: Implementation Medicinal Products
- HTAR: Capacity Building
- Joint Clinical Assessments Medicinal Products
- Amivantamab Plus Lazertinib vs Osimertinib Plus Chemotherapy
- Oncology Pipeline Monitor 2026
- Endometriosis: International Care Standards and Healthcare Reality in Vienna
- Implementing Rapid Recovery Programs in Total Hip and Knee Replacement Surgery
- Methodological Principles for Cost Calculations in Health Economic Studies (Part 2)
- Development of Austrian guidelines for health economic evaluations
- Telerehabilitation for people with neurological conditions
- Telemedical interventions to support exercise and physical activity goals for people with type 2 diabetes
- De-Implementierung of Low-Value-Care
- AIHTA Information Service − Rapid Reviews
- Annual Research Programme 2025
- Combination Therapy with Antidepressants and Vitamin B Complex Compared to Antidepressant Monotherapy
- Overview of National Health Economic Evaluation Guidelines: International Best Practices and Implications for Austria
- Guidance for Searching and Finding Public Contributions to Pharmaceutical R&D
- Music therapy: Clinical and socioeconomic outcomes and long-term measures in substance use disorder
- Transition from Child and Adolescent to Adult Mental Health Services: Analysis and Comparison of International Models
- Genetic Testing in Austria. Part C: Detection of PIK3CA/AKT1/PTEN/ESR1 genetic alterations in HR+/HER2– breast cancer
- Genetic Testing in Austria. Part B: Carrier Screening for Selected Genetic Conditions
- Genetic Testing in Austria. Part A: Application Fields and Prioritisation Criteria
- Structured Medication Review for Polypharmacy
- Health Economic Reference Cases and Costing Approaches
- Social Prescribing in Primary Care – Development of an Austrian programme theory based on realist evidence
- Telecardiology for heart failure patients: Benefit assessment and evaluation concept for telemedicine-supported care programmes in Austria
- AI-supported Chest X-Ray Analysis for Lung Cancer Detection
- Artificial Intelligence for Hospital Documentation Support
- Further Development of the Programme on Preventive Health Check-Ups in Austria: Screening for Chronic Kidney Disease – a rapid review on benefits, harms and target populations
- Further Development of the Programme on Preventive Medical Check-Ups in Austria. Risk Scores for Cardiovascular Disease: A Systematic Review
- Further Development of the Programme on Preventive Health Check-Ups in Austria: Brief interventions for lifestyle counselling Umbrella review and qualitative survey
- Systematic Review of the Long-Term Effectiveness and Safety of Enzyme Replacement Therapy in Mucopolysaccharidoses Disorders and Pompe Disease
- Nudges to Optimise Prescriber Behaviour of Physicians
- Digital health technologies
- CAR-T cell therapy
- Trauma Care
- Annual Research Programme 2024
- Artificial Intelligence in health care with a focus on hospitals: Methodological considerations for Health Technology Assessment
- Threshold values in health economic evaluations and decision-making
- Oncological Breast Cancer Care in Selected European Countries - Organisation of healthcare infrastructures and medical service provision
- ASSESS-DHT: Telehealth in Diabetes – EU mapping and systematic evaluation of organisational aspects
- Strategies to reduce weight stigmatisation of people with overweight or obesity in the healthcare sector
- Mental health screening of adults in primary care
- Point of Care Tests (POCT): D-Dimer and Troponin. Update 2024
- Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
- Annual Research Programme 2023
- Registries in Austria and their utilisation for healthcare improvement
- Image-guided spinal injections in the treatment of chronic spinal pain
- Strategies for recruitment and programme adherence in group programmes for children, adolescents and adults with overweight and grade 1 obesity
- Economic Dimensions of Community Nursing
- Oral and parenteral preexposure prophylaxis (PrEP) to prevent HIV in people at risk
- Perinatal and infant mental health care in Austria
- Roboterassistierte Chirurgie bei thorakalen und viszeralen Indikationen
- Sponsoring of patient initiatives in Austria
- PET/PET-CT evidence for need based planning in the area of oncology
- SMA-Therapies - Mid- to longer-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec as monotherapies or in combination, and patients treated for ≥12 months with risdiplam as monotherap
- Annual Research Programme 2022
- Quality Registries in Dementia Care: Mapping of Registries to improve Quality and Service Delivery
- Child and adolescent mental health care models
- Perinatal and infant mental health care models and pathways
- CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE)
- Risk-based breast cancer screening in Austria
- Osteopathy: effectiveness and safety for musculoskeletal pain and overview of training and quality requirements
- Telemonitoring in Austrian diabetes care
- Long COVID care pathways and structures
- Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
- ATMPs and Gene Therapies in Development - Horizon Scanning
- CAR-T Cell-Therapies in Development
- Annual Research Programme 2021
- The economic and societal dimension of parental mental illness
- Process and evaluation of digital health applications in the context of “symptom-checkers”
- Nivolumab in malignant melanoma: contrasting the evidence from the pivotal trials with the real world evidence (RWE)
- National strategies and programmes for preventing and managing non-communicable diseases in selected countries
- (Good) practice organizational models using real-world evidence for public funding of high prized therapies
- Long COVID care pathways
- Epidemiology of long COVID
- Stool DNA testing for colorectal cancer (CRC) screening
- Non-interventional studies (NIS) in Austria
- Bamlanivimab monotherapy and as combination therapy (with Etesevimab) for Covid-19
- Combination therapy Casirivimab plus Imdevimab (REGN-COV2) for the treatment of Covid-19
- Transparency: Sponsoring of patient initiatives in Austria
- ≥ 12 Month Follow-Up of Patients with Spinal Muscular Atrophy (SMA) treated with Spinraza®, Zolgensma® or Combination Therapies
- Annual Research Programme 2020
- Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
- Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia
- Lung Cancer Screening in Risk Groups (Part II)
- Lung cancer screening in risk groups
- Genetic Testing in the Context of Familial Hypercholesterolaemia Management
- Home-Treatment in Child and Adolescent Psychiatry
- Robotics and functional electrical stimulation for stroke rehabilitation
- Health Services Research in Oncology
- Health Services Research in Oncology
- CAR-T Celltherapies
- ATMPs and Gene Therapies in Development
- Parent-Child-Pass Update 2020/21 – Screenings for mental health, nutrition and social competence
- Proton and carbon ion therapy - an update on indications
- Update PET/PET-CT evidence for need based planning in the area of oncology
- Covid-19: HSS/ Horizon Scanning Living Document
- Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
- Annual Research Programme 2026
- Programme Lines
- Publications
- Contact
- Legal Notice
- Privacy Policy
- Accessibility Statement
- Sitemap
- Newsletter Subscription
- Search
- 404 page not found